Halberg D F, Wager R E, Farrell D C, Hildreth J, Quesenberry M S, Loeb J A, Holland E C, Drickamer K
J Biol Chem. 1987 Jul 15;262(20):9828-38.
Preparations of the rat liver asialoglycoprotein receptor (rat hepatic lectin, RHL), which is responsible for the selective uptake of partially deglycosylated serum glycoproteins, have been found to contain multiple polypeptide species. A method has been developed for separating the predominant species (RHL-1) from the minor species (RHL-2/3) using conditions in which RHL-1 retains its galactose-binding activity. Endoglycosidase digestion and lectin blotting have been utilized to demonstrate that RHL-2 and RHL-3 differ by the presence of different carbohydrate structures attached to a common peptide backbone. Antisera specific for RHL-1 and RHL-2/3 have been prepared and utilized to analyze the results of cross-linking experiments performed on purified receptor and hepatocyte membranes. The results show that RHL-1 and RHL-2/3 polypeptides are each associated into homooligomers but are physically unlinked to each other. The structure of the RHL-2/3 polypeptide has been established by protein and cDNA sequence analysis, which reveals that this protein is homologous to RHL-1 throughout its length but contains one major insertion of 18 amino acids near its NH2 terminus. The COOH-terminal portion of the RHL-2/3 polypeptide has been demonstrated to contain a galactose-recognition domain by expression in an in vitro transcription/translation system. The results of these experiments indicate that RHL-1 and RHL-2/3 polypeptides are self-associated into two distinct molecules, each of which has galactose-binding activity.
大鼠肝脏去唾液酸糖蛋白受体(大鼠肝凝集素,RHL)制剂负责部分去糖基化血清糖蛋白的选择性摄取,已发现其含有多种多肽种类。已开发出一种方法,利用RHL-1保留其半乳糖结合活性的条件,将主要种类(RHL-1)与次要种类(RHL-2/3)分离。已利用内切糖苷酶消化和凝集素印迹法证明,RHL-2和RHL-3的差异在于连接在共同肽主链上的不同碳水化合物结构的存在。已制备了针对RHL-1和RHL-2/3的特异性抗血清,并用于分析对纯化受体和肝细胞膜进行的交联实验结果。结果表明,RHL-1和RHL-2/3多肽各自缔合成同型寡聚体,但彼此在物理上未连接。RHL-2/3多肽的结构已通过蛋白质和cDNA序列分析确定,结果表明该蛋白质在其全长范围内与RHL-1同源,但在其NH2末端附近含有一个18个氨基酸的主要插入片段。通过在体外转录/翻译系统中的表达,已证明RHL-2/3多肽的COOH末端部分含有半乳糖识别结构域。这些实验结果表明,RHL-1和RHL-2/3多肽各自自缔合成两个不同的分子,每个分子都具有半乳糖结合活性。